Cargando…
Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo
In relation to the recent trials of Intravenous Immunoglobulin (IVIG) in Alzheimer’s Disease (AD) it was demonstrated that different IgG preparations contain varying amounts of natural anti-amyloid β (Aβ) antibodies as measured by ELISA. We therefore investigated the relevance of ELISA data for meas...
Autores principales: | Cattepoel, Susann, Gaida, Annette, Kropf, Alain, Nolte, Marc W., Bolli, Reinhard, Miescher, Sylvia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999199/ https://www.ncbi.nlm.nih.gov/pubmed/27561008 http://dx.doi.org/10.1371/journal.pone.0161826 |
Ejemplares similares
-
Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro
por: Cattepoel, Susann, et al.
Publicado: (2013) -
IgG Glyco-Engineering to Improve IVIg Potency
por: Bruggeman, Christine W., et al.
Publicado: (2018) -
Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates
por: Vonarburg, Cédric, et al.
Publicado: (2019) -
IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2021) -
Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation
por: Kustiawan, Iwan, et al.
Publicado: (2018)